Deep-sea marine sponges may hold key to antibiotic drug resistance
(Florida Atlantic University) FAU's Harbor Branch houses more than 1,000 strains of actinobacteria, one of the most prolific microbial groups for the production of natural products. Derived from sea sponges and other macro-organisms, several strains were identified for their potent antifungal activity, for anti-MRSA activity, and for both antifungal and antibacterial activities. A key finding was the identification of a strain that produced metabolites that are more potent than the bacterial antibiotic, vancomycin, against C. difficile. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 19, 2018 Category: Infectious Diseases Source Type: news

Test can identify ICU patients at most risk of serious infections
A new test can identify intensive care patients at highest risk of potentially life-threatening secondary infections, including from antibiotic-resistant bacteria such as MRSA and C difficile, according to UK researchers. (Source: Nursing Times)
Source: Nursing Times - June 18, 2018 Category: Nursing Source Type: news

New compound as effective as FDA-approved drugs against life-threatening infections
(Purdue University) Purdue University researchers have identified a new compound that in preliminary testing has shown itself to be as effective as antibiotics approved by the FDA to treat life-threatening infections while also appearing to be less susceptible to bacterial resistance.The compound has been potent against antibiotic-resistant pathogens such as MRSA, which is often found in hospitals and other health care settings, and vancomycin-resistant Staphylococcus, with vancomycin long considered a drug of last resort. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 15, 2018 Category: Infectious Diseases Source Type: news

Test can identify patients in intensive care at risk of life-threatening infections
(University of Cambridge) Patients in intensive care units are at significant risk of potentially life-threatening secondary infections, including from antibiotic-resistant bacteria such as MRSA and C. difficile. Now, a new test could identify those at greatest risk -- and speed up the development of new therapies to help at-risk patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 13, 2018 Category: International Medicine & Public Health Source Type: news

CDC: Invasive MRSA More Likely Among Injection Drug Users
MONDAY, June 11, 2018 -- Injection drug users are more than 16-fold more likely to develop invasive methicillin-resistant Staphylococcus aureus (MRSA) infections, according to research published in the June 8 issue of the U.S. Centers for Disease... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 11, 2018 Category: Pharmaceuticals Source Type: news

Superbug Infections Rising Among Injection Drug Users
NEW YORK (AP) — One type of superbug bacteria is increasingly spreading among people who inject drugs, according to a new government report. Users of heroin and other injection drugs were 16 times more likely than other people to develop severe illnesses from MRSA, said the report published Thursday. "Drug use has crept up and now accounts for a substantial proportion of these very serious infections," said Dr. William Schaffner of Vanderbilt University, one of the study's authors. The U.S. is in the midst of its deadliest drug epidemic ever. While overdose deaths have been the main concern, some studies ha...
Source: JEMS Patient Care - June 8, 2018 Category: Emergency Medicine Authors: Mike Stobbe, Associated Press Tags: Patient Care News Source Type: news

Superbug Infections Rising Among Injection Drug Users
NEW YORK (AP) — One type of superbug bacteria is increasingly spreading among people who inject drugs, according to a new government report. Users of heroin and other injection drugs were 16 times more likely than other people to develop severe illnesses from MRSA, said the report published Thursday. "Drug use has crept up and now accounts for a substantial proportion of these very serious infections," said Dr. William Schaffner of Vanderbilt University, one of the study's authors. The U.S. is in the midst of its deadliest drug epidemic ever. While overdose deaths have been the main concern, some studies ha...
Source: JEMS: Journal of Emergency Medical Services News - June 8, 2018 Category: Emergency Medicine Authors: Mike Stobbe, Associated Press Tags: Patient Care News Source Type: news

Superbug infections rising among users who inject drugs
New research suggests users of heroin and other injection drugs are 16 times more likely than other people to develop severe illnesses from MRSA (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - June 7, 2018 Category: Consumer Health News Source Type: news

Superbug infections rising among injection drug users
Users of heroin and other injection drugs were 16 times more likely than other people to develop severe illnesses from MRSA, said the report published Thursday. (Source: the Mail online | Health)
Source: the Mail online | Health - June 7, 2018 Category: Consumer Health News Source Type: news

Superbug infections rising among users who inject drug
New research suggests users of heroin and other injection drugs are 16 times more likely than other people to develop severe illnesses from MRSA (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - June 7, 2018 Category: Consumer Health News Source Type: news

Invasive Methicillin-Resistant Staphylococcus aureus Infections Among Persons Who Inject Drugs — Six Sites, 2005–2016
(Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - June 7, 2018 Category: American Health Source Type: news

New compound effective against drug-resistant pathogens, could lead to new antibiotics
(North Carolina State University) Researchers have synthesized an analog of lipoxazolidinone A, a small molecule that is effective against drug-resistant bacteria such as MRSA. This molecule, a new synthetic compound inspired by a natural product, could be a useful chemical tool for studying other Gram-positive infections and may have implications for future drug creation. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 30, 2018 Category: Biology Source Type: news

Collaboration Needed to Fight Antimicrobial Resistance
Antimicrobial resistance (AMR) is one of the greatest threats to human health throughout the world, warns Gary Cohen, executive vice president of global health for BD. “There is an increasing risk of going back to the pre-antibiotic era,” he told MD+DI. “Resistance is not a new issue—it is just a bigger problem, at an accelerated pace. Because antibiotics have been overprescribed for humans as well as overused in food production, antimicrobial resistance is not just a theoretical threat.” Everyone needs to play a role, including diagnostics manufacturers and even medical device innovators, he ...
Source: MDDI - May 26, 2018 Category: Medical Devices Authors: Daphne Allen Tags: IVD Source Type: news

More frequent checks control MRSA in newborns, but can hospitals afford them?
(Drexel University) Checking more often on newborns in the NICU provided positive results for preventing MRSA transmission, but hospitals must balance the high costs, a new study found. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 22, 2018 Category: International Medicine & Public Health Source Type: news

Study: Superbug MRSA infections less costly, but still deadly
(UT Southwestern Medical Center) Drug-resistant staph infections continue to be deadlier than those that are not resistant and treatable with traditional antibiotics, but treatment costs surprisingly are the same or slightly less, a new national analysis shows. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 15, 2018 Category: Infectious Diseases Source Type: news

Using MRSA's strength against it
(Michigan State University) MRSA evolved to become a deadly killer because it's wily and resilient. A new Michigan State University study, however, is figuring out how to turn one of its strengths against it. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 14, 2018 Category: Infectious Diseases Source Type: news

CA-MRSA Rates Among Student Athletes Highest in Contact Sports CA-MRSA Rates Among Student Athletes Highest in Contact Sports
Reuters Health Information (Source: Medscape Orthopaedics Headlines)
Source: Medscape Orthopaedics Headlines - May 10, 2018 Category: Orthopaedics Tags: Infectious Diseases News Source Type: news

Treatment for MRSA no longer more costly than for susceptible Staph aureus infections
(Center for Disease Dynamics, Economics& Policy) A new study found that infections caused by one of the most common drug resistant bacteria in the US -- methicillin-resistant Staphylococcus aureus, known as MRSA -- are no more expensive to treat than MSSA, the methicillin-susceptible version of the same bacteria. These findings are contrary to earlier studies that have found that MRSA was much more expensive to treat than MSSA. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 10, 2018 Category: Infectious Diseases Source Type: news

NHS trusts are spending millions outsourcing staff to private companies, says UNISON
NHS trusts across England are spending millions of pounds outsourcing staff to new arms-length private companies, says UNISON today (Monday). Using a Freedom of Information (FoI) request, UNISON has revealed that NHS trusts are shelling-out huge amounts of money on consultants. These companies are advising trusts on the setting up of wholly owned subsidiaries, to which staff are then outsourced. UNISON says that these new companies appeal to NHS trusts because they can reduce their VAT payments, and cut the pay and pensions for any new staff recruited. The health workers that are being transferred tend to be the lowest pai...
Source: UNISON meat hygiene - April 15, 2018 Category: Food Science Authors: Clare Santry Tags: Press release 2018 Health Conference Freedom of information NHS wholly owned subsidiaries Source Type: news

Six children affected by MRSA on same ward
Six babies in a neonatal intensive care unit have been found to be colonised with the same strain of MRSA – leading to staff being tested and three being identified as carriers of the bacteria. (Source: HSJ)
Source: HSJ - April 6, 2018 Category: UK Health Source Type: news

Updated guidance on MRSA post infection review
NHS Improvement has updated its guidance on MRSA post infection review. The updated guidance can be found on the NHS Improvement website. (Source: NHS Networks)
Source: NHS Networks - April 3, 2018 Category: UK Health Source Type: news

Scientists find class of drug that can kill the MRSA superbug
Researchers at Brown University have found two new compounds successfully treated antibiotic-resistant MRSA infections in mice, a key step as health officials warn of impending crisis. (Source: the Mail online | Health)
Source: the Mail online | Health - March 28, 2018 Category: Consumer Health News Source Type: news

Discovery of MRSA-busting antibiotic gives hope against resistant superbugs
New drug tested on mice could be used to treat human infections that no longer respond to routine antibiotics, say scientistsThe discovery of a new class of antibiotics that can wipe out persistent infections of the hospital superbug MRSA has raised fresh hopes for progress in the fight againstantimicrobial resistance.Health officials around the world have seen a steady rise in bacterial infections that no longer respond to routine antibiotics. With resistance emerging faster than new drugs can be developed, the World Health Organisation (WHO) has called forurgent action to combat the problem.Continue reading... (Source: G...
Source: Guardian Unlimited Science - March 28, 2018 Category: Science Authors: Ian Sample Science editor Tags: Antibiotics Drug resistance Science MRSA and superbugs Health Society World news Source Type: news

Antibiotic breakthrough: Fcientists find class of drug that can kill the MRSA superbug  
Researchers at Brown University have found two new compounds successfully treated antibiotic-resistant MRSA infections in mice, a key step as health officials warn of impending crisis. (Source: the Mail online | Health)
Source: the Mail online | Health - March 28, 2018 Category: Consumer Health News Source Type: news

Newly Discovered Antibiotic Drug Offers Hope For Treating MRSA
A new class of antibiotics, chemically related to vitamin A have shown early promise by killing MRSA in mice. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 28, 2018 Category: Pharmaceuticals Authors: Victoria Forster, Contributor Source Type: news

MRSA: guidance on post-infection review
This update describes the detailed requirements for the reporting and review of bloodstream infections caused by MRSA from April 2018 and includes lists of the trusts and CCGs that will need to carry out post-infection reviews. It will support commissioners and providers of care to deliver zero tolerance on MRSA BSI. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - March 28, 2018 Category: Consumer Health News Source Type: news

Medical News Today: 'Game-changing' antibiotic can kill off superbugs
The antibiotic teixobactin may succeed where others have failed; a synthetic version of it clears an infection with a drug-resistant superbug in mice. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 27, 2018 Category: Consumer Health News Tags: MRSA / Drug Resistance Source Type: news

First proof a synthesized antibiotic is capable of treating superbugs
A "game changing" new antibiotic which is capable of killing superbugs has been successfully synthesised and used to treat an infection for the first time - and could lead to the first new class of antibiotic drug in 30 years. The breakthrough is another major step forward on the journey to develop a commercially viable drug version based on teixobactin - a natural antibiotic discovered by US scientists in soil samples in 2015 which has been heralded as a "gamechanger" in the battle against antibiotic resistant pathogens such as MRSA and VRE. (Source: World Pharma News)
Source: World Pharma News - March 23, 2018 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Super-fit Ben was left fighting a deadly superbug
Ben May, from Haslemere in Surrey, was a popular Oxford University student when a chance infection rendered him bed-ridden for 44 days. This is his cautionary MRSA tale. (Source: the Mail online | Health)
Source: the Mail online | Health - March 20, 2018 Category: Consumer Health News Source Type: news

Super-fit Ben, 21, was left fighting a deadly superbug
Ben May, from Haslemere in Surrey, was a popular Oxford University student when a chance infection rendered him bed-ridden for 44 days. This is his cautionary MRSA tale. (Source: the Mail online | Health)
Source: the Mail online | Health - March 19, 2018 Category: Consumer Health News Source Type: news

Plasmid-Encoded Transferable mecB-Resistance in S. aureus Plasmid-Encoded Transferable mecB-Resistance in S. aureus
The discovery of plasmid-encoded methicillin resistance in S. aureus could have important implications for MRSA treatment.Emerging Infectious Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 15, 2018 Category: Consumer Health News Tags: Infectious Diseases Journal Article Source Type: news

Research project on dangerous hospital germ extended
(Goethe University Frankfurt) Cases of multi-resistant bacteria in hospitals have increased dramatically in recent years and the health system faces tremendous problems as a result. Alongside 'old acquaintances', such as Staphylococcus aureus (MRSA) or Klebsiella pneumonia, another pathogen has now arrived on the scene: Acinetobacter baumannii. In order to find new weapons for the fight against this aggressive germ, in 2014 the German Research Foundation established a Research Unit led by Goethe University Frankfurt which has now been extended for a further three years. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 7, 2018 Category: International Medicine & Public Health Source Type: news

AAAAI: Penicillin Allergy Label Linked to MRSA, C. difficile
(MedPage Today) -- Increase attributable to use of alternative antibiotics (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - March 5, 2018 Category: Infectious Diseases Source Type: news

Influenza and MRSA Pneumonia Influenza and MRSA Pneumonia
Dr Paul Auwaerter discusses the antimicrobial options for postinfluenza MRSA pneumonia, and makes the case for a universal flu vaccine.Medscape Infectious Diseases (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - March 5, 2018 Category: Infectious Diseases Tags: Infectious Diseases Commentary Source Type: news

A Potentially Powerful New Antibiotic Is Discovered in Dirt
The world is facing an epidemic of infections that no longer respond well to the drugs used to treat them—also known as super bugs. In the United States, an estimated 2 million Americans are diagnosed each year with an infection that doesn’t respond to antibiotics, and 23,000 will die from those infections. But New York and New Jersey researchers published a new paper in the journal Nature Microbiology about their hopeful discovery: a potentially new class of antibiotic that they found in dirt. In the lab, the researchers used a method to extract, clone and sequence DNA from soil samples to see if there are gen...
Source: TIME: Health - February 14, 2018 Category: Consumer Health News Authors: Alexandra Sifferlin Tags: Uncategorized healthytime public health Source Type: news

Crystal Whitley on life support after two strains of flu  
Crystal Whitley, 35, of Mullin, Texas, is on life support after contracting two strains of the flu virus. She was diagnosed with sepsis, double pneumonia, and MRSA, (Source: the Mail online | Health)
Source: the Mail online | Health - February 13, 2018 Category: Consumer Health News Source Type: news

New antibiotic family discovered in dirt
The compounds are called malacidins and can kill several stubborn infections, including superbug MRSA. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - February 13, 2018 Category: Consumer Health News Source Type: news

Teacher, 35, on life support after catching the flu  
Crystal Whitley, 35, of Mullin, Texas, is on life support after contracting two strains of the flu virus. She was diagnosed with sepsis, double pneumonia, and MRSA, (Source: the Mail online | Health)
Source: the Mail online | Health - February 12, 2018 Category: Consumer Health News Source Type: news

This UV Lamp Could Prevent the Flu Virus From Spreading in Public Places
Researchers have developed an ultraviolet (UV) lamp that kills the influenza virus but isn’t harmful to human skin or eyes, according to a new study in Scientific Reports. They hope the technology can be commercialized and marketed to prevent the spread of seasonal flu in public places, such as schools, hospitals, and airports. “We’ve known for a century that UV light is extremely efficient at killing microbes, bacteria, and viruses,” says study leader David Brenner, director of the Center for Radiological Research at Columbia University Irving Medical Center. For that reason, UV devices are often u...
Source: TIME: Health - February 9, 2018 Category: Consumer Health News Authors: Amanda MacMillan Tags: Uncategorized health healthytime onetime Source Type: news

New research suggests your immune system can protect against MRSA infections
After years of investigation, researchers at Johns Hopkins, the University of California, Davis, and the National Institute of Allergy and Infectious Diseases have discovered how the immune system might protect a person from recurrent bacterial skin infections caused by Staphylococcus aureus (staph). The findings, publishing online in The Journal of Clinical Investigation, open new doors to someday developing vaccines to prevent staph skin infections, which account for 14 million outpatient visits, nearly 500,000 hospital admissions and $3 billion to $4 billion in inpatient health care costs in the U.S. per year. (Source: World Pharma News)
Source: World Pharma News - February 5, 2018 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

New research suggests your immune system can protect against MRSA infections
(Johns Hopkins Medicine) After years of investigation, researchers at Johns Hopkins, the University of California, Davis, and the National Institute of Allergy and Infectious Diseases have discovered how the immune system might protect a person from recurrent bacterial skin infections caused by Staphylococcus aureus (staph). (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 5, 2018 Category: Infectious Diseases Source Type: news

Appointment of Jonathan E. Gold as Interim Chief Financial Officer
NEW YORK, Feb. 02, 2018 -- (Healthcare Sales & Marketing Network) -- Motif Bio plc (AIM:MTFB) (NASDAQ:MTFB) ("Motif Bio" or the "Company"), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today a... Biopharmaceuticals, Personnel Motif Bio, multi-drug resistant bacteria, MRSA (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 2, 2018 Category: Pharmaceuticals Source Type: news

FDA OKs First Vancomycin Oral Solution for C diff Diarrhea FDA OKs First Vancomycin Oral Solution for C diff Diarrhea
Vancomycin hydrochloride for oral solution (Firvanq) is for treatment of Clostridium difficile-associated diarrhea and enterocolitis caused by Staphylococcus aureus, including methicillin-resistant strains.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 30, 2018 Category: Consumer Health News Tags: Infectious Diseases News Alert Source Type: news

Medical News Today: Drug resistance: Could these onions help us win the war?
Researchers find that compounds from a species of onion can kill the tuberculosis bacterium. Could this be the key to combatting drug resistance? (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 24, 2018 Category: Consumer Health News Tags: MRSA / Drug Resistance Source Type: news

Lymphatics limp along after MRSA
(Source: ScienceNOW)
Source: ScienceNOW - January 18, 2018 Category: Science Authors: Pujanandez, L. Tags: twis Source Type: news

Mass. General study reveals how MRSA infection compromises lymphatic function
(Massachusetts General Hospital) Massachusetts General Hospital investigators find that MRSA infection impairs the ability of lymphatic vessels to pump lymphatic fluid to lymph nodes in mouse models, which may contribute to the frequent recurrences of MRSA infection experienced by patients. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - January 17, 2018 Category: Infectious Diseases Source Type: news

Guidelines Issued on Contact Precautions for MRSA, C. difficile
The Society for Healthcare Epidemiology of America has issued guidelines on how long contact precautions in acute-care hospitals should persist for numerous drug-resistant... (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - January 12, 2018 Category: Primary Care Source Type: news

SURGICEL & #194; & #174; Powder Absorbable Hemostat is used in surgeries.
SURGICEL® Powder Absorbable Hemostat is used for broad-surface oozing and stops bleeding fast. Unit is suitable for gynecologic, oncologic, cardiovascular and general procedure applications. Product offers bactericidal activity in vitro against MRSA, MRSE, VRE, PRSP, E Coli pathogens.This story is related to the following:Hemostats (Source: Industrial Newsroom - Health, Medical and Dental Supplies)
Source: Industrial Newsroom - Health, Medical and Dental Supplies - January 10, 2018 Category: Medical Devices Source Type: news

Kent State researcher exposes MRSA risk at northeast Ohio beaches
(Kent State University) Tara C. Smith, Ph.D., a professor of epidemiology in Kent State's College of Public Health, published the findings of a study her lab conducted in 2015 that shows a higher-than-expected prevalence of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus (MRSA) at beaches around Lake Erie. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 14, 2017 Category: Infectious Diseases Source Type: news